Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ants Toi

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
BJU International|December 9, 2016
Development and external validation of a biopsy-derived nomogram to predict risk of ipsilateral extraprostatic extensionRashid Sayyid, Nathan Perlis, Ardalanejaz Ahmad, et al.
The Journal of Urology|September 30, 2015
An Increase in Gleason 6 Tumor Volume While on Active Surveillance Portends a Greater Risk of Grade Reclassification with Further FollowupMaria Komisarenko, Lih-Ming Wong, Patrick O Richard, et al.
The Journal of Urology|January 13, 2006
Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsyRobert K Nam, Ants Toi, John Trachtenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
The use of genetic markers to determine risk for prostate cancer at prostate biopsyRobert K Nam, William W Zhang, Michael A S Jewett, et al.
The Journal of Urology|April 19, 2014
Regular transition zone biopsy during active surveillance for prostate cancer may improve detection of pathological progressionLih-Ming Wong, Ants Toi, Theodorus Van der Kwast, et al.
BJU International|December 22, 2004
Variation in patterns of practice in diagnosing screen-detected prostate cancerRobert K Nam, Ants Toi, John Trachtenberg, et al.
The Canadian Journal of Urology|August 2, 2003
Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomyRobert K Nam, Michael A S Jewett, Murray D Krahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Assessing individual risk for prostate cancerRobert K Nam, Ants Toi, Laurence H Klotz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2012
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancerMichael Milosevic, Padraig Warde, Cynthia Ménard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detectionRobert K Nam, William W Zhang, John Trachtenberg, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
BJU International|December 9, 2016
Development and external validation of a biopsy-derived nomogram to predict risk of ipsilateral extraprostatic extensionRashid Sayyid, Nathan Perlis, Ardalanejaz Ahmad, et al.
The Journal of Urology|September 30, 2015
An Increase in Gleason 6 Tumor Volume While on Active Surveillance Portends a Greater Risk of Grade Reclassification with Further FollowupMaria Komisarenko, Lih-Ming Wong, Patrick O Richard, et al.
The Journal of Urology|January 13, 2006
Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsyRobert K Nam, Ants Toi, John Trachtenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
The use of genetic markers to determine risk for prostate cancer at prostate biopsyRobert K Nam, William W Zhang, Michael A S Jewett, et al.
The Journal of Urology|April 19, 2014
Regular transition zone biopsy during active surveillance for prostate cancer may improve detection of pathological progressionLih-Ming Wong, Ants Toi, Theodorus Van der Kwast, et al.
BJU International|December 22, 2004
Variation in patterns of practice in diagnosing screen-detected prostate cancerRobert K Nam, Ants Toi, John Trachtenberg, et al.
The Canadian Journal of Urology|August 2, 2003
Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomyRobert K Nam, Michael A S Jewett, Murray D Krahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Assessing individual risk for prostate cancerRobert K Nam, Ants Toi, Laurence H Klotz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2012
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancerMichael Milosevic, Padraig Warde, Cynthia Ménard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detectionRobert K Nam, William W Zhang, John Trachtenberg, et al.
Pageof 11